BAODING, China, Aug. 11,
2024 /PRNewswire/ -- A landmark German delegation,
led by world-renowned stem cell expert Prof. Dato' Sri Dr.
Mike Chan, concluded a three-day
visit to Baoding, China, marking a
significant step in international health cooperation. The visit,
from July 11-13, reciprocated an
earlier Chinese governmental visit to Germany in June, which focused on
collaboration in stem cell research, biotechnology, health, and
medical education.
Prof. Chan, founder of the European Wellness Biomedical Group
(EW Group), stands at the forefront of stem cell research. Under
his leadership, the EW Group has become a multi-award-winning
organization pioneering precursor stem cell therapeutics,
immunomodulation, and biological regenerative medicine
internationally.
Prof Chan's appointment as a Senator of the German Federal
Association for Economic Development and Foreign Trade (BWA) since
2018, plays a crucial role in fostering economic development and
foreign trade relations between Germany and key Asian nations. This
government-led appointment underscores his international
recognition and influence in the field of stem cell research and
regenerative medicine in driving cross-border
innovations.
The visit, organized by Michel
Schumann, Chairman of the BWA, culminated in the signing of
five agreements covering health and educational cooperation, oral
medicine, cell therapy technology, medical rehabilitation, and
elderly care. Top officials in Baoding, including Municipal Party
Committee Secretary Dang Xiaolong, Deputy Secretary and Mayor
Yan Jihong, and Meng Qing Yu, vice-president of Hebei University, warmly welcomed the
delegates.
During the visit, the German delegation visited schools and a
children's hospital. They interacted with students, teachers, and
medical staff, promoting careers in biotechnology and medical
research. The Chinese officials showed strong interest in Prof.
Chan's groundbreaking technology for treating children with special
needs, including autism, Down syndrome, cerebral palsy, and global
developmental delays.
Prof. Chan's expertise is particularly notable in the field of
targeted organ and brain-specific precursor stem cells, having
developed over 400 types. Dang Xiaolong emphasized the potential
for learning and collaboration between Chinese and German
counterparts in this area.
A key symposium facilitated discussions on potential
collaborations, with notable participants including Claus Biermann, Director of the Big Health
Committee, Sebastian Schutz, General
Manager of the German Federal Pharmaceutical Industry Association,
and Prof. Ulrich Joos. An MOU on
joint stem cell research and education collaboration was signed
between the European Wellness Bio Medical Group and San Zang,
witnessed by Chinese officials and the German delegation.
With over 50 international patents and authorship of more than
50 books and 100 scientific publications, two of Prof. Chan's
notable works include, "Stem Cells in Regenerative Medicine" and
"Autism Spectrum Disorder: An Integrative Approach," cement his
status as a leading authority in stem cell research and its
applications in treating neurodevelopmental disorders.
Currently, Prof. Chan is collaborating with Heidelberg
University in Germany on
cutting-edge research into neurodevelopmental diseases. This
partnership combines his expertise in stem cell therapy with
Heidelberg University's renowned medical research facilities,
focusing on developing innovative treatments for conditions such as
autism, Down syndrome, and cerebral palsy using targeted
brain-specific precursor stem cells.
As Germany and China work together to advance medical science
and improve healthcare systems, the benefits are expected to impact
global health standards and pave the way for further advancements
in medical education, stem cell research, and even traditional
Chinese medicine.
Dang Xiaolong concluded that the visit culminated in fruitful
collaboration between academic and medical institutions,
strengthening bonds between both countries and contributing to
positive outcomes for both nations. This partnership not only
enhances Sino-German relations but also promises significant
advancements in treating complex neurological conditions,
potentially benefiting patients worldwide.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/german-stem-cell-expert-leads-delegation-to-boost-sino-german-health--educational-cooperation-302219556.html
SOURCE EWBG